Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients

被引:40
作者
Grace, ME [1 ]
Desnick, RJ [1 ]
Pastores, GM [1 ]
机构
[1] MT SINAI SCH MED, DEPT PEDIAT, NEW YORK, NY 10029 USA
关键词
Baculoviridae; mutagenesis; site-directed; recombinant; enzymology; genotype;
D O I
10.1172/JCI119437
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gaucher disease, the most prevalent lysosomal storage disease, occurs in three subtypes, all resulting from mutations in the acid beta-glucosidase gene, Molecular studies in five severely affected type 1 and two type 2 Gaucher disease patients of non-Jewish descent identified six new mutations: K74X, W179X, G195E, S271N, V352L, and a two-base deletion in exon 10 (1450del2), Two additional mutations identified in these patients (R48W and G202R) have been reported previously, but were not expressed or characterized, Heterologous expression in Sf9 cells using the baculovirus system revealed that the missense mutations, R48W and V352L, had 14 and 7%, respectively, of the specific activity based on cross-reacting immunologic material expressed by the normal allele, In contrast, the G195E, G202R, and S271N mutant alleles were more severely compromised with only 1-2% of the normal expressed specific activity based on cross-reacting immunologic material, Structural distortion at the active site was probed by comparing the interaction of the mutant enzymes with active site-directed inhibitors (castanospermine, conduritol B epoxide and deoxynojirimycin), R48W, G202R, and S271N were normally inhibited, whereas the V352L and G195E mutant enzymes had significantly decreased binding affinity, These mutations further expand the genetic heterogeneity in the lesions causing Gaucher disease types 1 and 2, and further delineate genotype/phenotype correlations and functional domains within the acid beta-glucosidase gene.
引用
收藏
页码:2530 / 2537
页数:8
相关论文
共 49 条
[1]   RESTRICTION SITES CONTAINING CPG SHOW A HIGHER FREQUENCY OF POLYMORPHISM IN HUMAN DNA [J].
BARKER, D ;
SCHAFER, M ;
WHITE, R .
CELL, 1984, 36 (01) :131-138
[2]   ASSIGNMENT OF THE GENE CODING FOR HUMAN BETA-GLUCOCEREBROSIDASE TO THE REGION Q21-Q31 OF CHROMOSOME-1 USING MONOCLONAL-ANTIBODIES [J].
BARNEVELD, RA ;
KEIJZER, W ;
TEGELAERS, FPW ;
GINNS, EI ;
GEURTSVANKESSEL, A ;
BRADY, RO ;
BARRANGER, JA ;
TAGER, JM ;
GALJAARD, H ;
WESTERVELD, A ;
REUSER, AJJ .
HUMAN GENETICS, 1983, 64 (03) :227-231
[3]  
BERGFUSSMAN A, 1993, J BIOL CHEM, V268, P14861
[4]   POLYMORPHISMS IN THE HUMAN GLUCOCEREBROSIDASE GENE [J].
BEUTLER, E ;
WEST, C ;
GELBART, T .
GENOMICS, 1992, 12 (04) :795-800
[5]   GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE [J].
BEUTLER, E ;
DEMINA, A ;
GELBART, T .
MOLECULAR MEDICINE, 1994, 1 (01) :82-92
[6]   5 NEW GAUCHER-DISEASE MUTATIONS [J].
BEUTLER, E ;
GELBART, T ;
DEMINA, A ;
ZIMRAN, A ;
LECOUTRE, P .
BLOOD CELLS MOLECULES AND DISEASES, 1995, 21 (01) :20-24
[7]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[8]   GAUCHER DISEASE AS A PARADIGM OF CURRENT ISSUES REGARDING SINGLE-GENE MUTATIONS OF HUMANS [J].
BEUTLER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5384-5390
[9]   Hematologically important mutations: Gaucher disease [J].
Beutler, E ;
Gelbart, T .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (01) :2-7
[10]   GAUCHER DISEASE ASSOCIATED WITH A UNIQUE KPNI RESTRICTION SITE - IDENTIFICATION OF THE AMINO-ACID SUBSTITUTION [J].
BEUTLER, E ;
GELBART, T .
ANNALS OF HUMAN GENETICS, 1990, 54 :149-153